(T 96) Effect of Atogepant Versus Topiramate on Cognitive Function in Migraine: Post Hoc Subgroup Analyses From the TEMPLE Trial Among Treatment Responders and Those With Cognitive Dysfunction-Related TEAEs

Presenting Author(s)

AV

Annelies Van Dycke, MD, PhD, MBA

General Hospital Sint-Jan Bruges
Brugge, West-Vlaanderen, United States
CL

Christian Lampl, MD, PhD

Konventhospital Barmherzige Brüder Linz, United States
YL

Yingyi Liu, PhD

AbbVie Inc.
Chicago, Illinois, United States
JS

Jonathan T. Stokes, MBA

AbbVie Inc.
Chicago, Illinois, United States
KN

Krisztian Nagy, MD, MSc

AbbVie Inc.
North Chicago, Illinois, United States
KC

Karen Carr, PharmD

AbbVie Inc.
North Chicago, Illinois, United States
UR

Uwe Reuter, MD, PhD, MBA

Physician
Charité Universitätsmedizin Berlin
Berlin, Berlin, United States
Richard B. Lipton, MD

Edwin S. Lowe Professor and Vice Chair of Neurology; Director, Montefiore Headache Center
Montefiore Medical Center and the Albert Einstein College of Medicine
Bronx, New York, United States